Evercore Forecasts Strong Price Appreciation for Humana (NYSE:HUM) Stock

Humana (NYSE:HUM) had its target price increased by research analysts at Evercore from $250.00 to $370.00 in a research note issued on Thursday,MarketScreener reports. Evercore’s target price indicates a potential downside of 0.07% from the company’s previous close.

Several other research analysts have also weighed in on HUM. JPMorgan Chase & Co. increased their price objective on Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research report on Monday. The Goldman Sachs Group upped their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. Barclays increased their price target on Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 26th. Morgan Stanley raised their price objective on Humana from $217.00 to $249.00 and gave the stock an “underweight” rating in a research report on Thursday, June 4th. Finally, Mizuho upped their target price on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $291.35.

Humana Trading Up 1.6%

Humana stock traded up $5.79 during midday trading on Thursday, hitting $370.25. 113,094 shares of the stock were exchanged, compared to its average volume of 1,882,474. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock’s 50-day simple moving average is $259.94 and its 200 day simple moving average is $235.20. Humana has a fifty-two week low of $163.11 and a fifty-two week high of $370.00. The stock has a market capitalization of $44.45 billion, a price-to-earnings ratio of 39.60, a PEG ratio of 2.08 and a beta of 0.76.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue was up 23.5% on a year-over-year basis. During the same period in the previous year, the business posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts anticipate that Humana will post 9 EPS for the current year.

Institutional Investors Weigh In On Humana

Hedge funds have recently added to or reduced their stakes in the business. Illinois Municipal Retirement Fund grew its position in shares of Humana by 9.6% during the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after buying an additional 4,351 shares in the last quarter. Long Focus Capital Management LLC purchased a new position in Humana in the third quarter valued at $34,212,000. AMG National Trust Bank increased its holdings in Humana by 106.5% in the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock valued at $4,411,000 after buying an additional 8,744 shares during the last quarter. Aberdeen Group plc raised its stake in Humana by 18.1% in the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after buying an additional 43,442 shares in the last quarter. Finally, Alberta Investment Management Corp purchased a new stake in Humana during the 3rd quarter worth about $4,735,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.